uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted September 18, 2012

Consumers Warned Not To Use Gastrointestinal Product Containing Withdrawn Prescription Drug

On September 18, 2012, the FDA issued a warning to consumers not to use Intestinomicina, a drug product marketed for the treatment of infectious diarrhea and acute gastrointestinal infections. Intestinomicina contains Chloramphenicol, a prescription drug withdrawn from the United States market in July 2012 due to the potential for serious and life-threatening injuries, including bone marrow toxicity.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at